Although researchers have reported good tumor targeting with such a short blood half-life, others have worked to extend the half-life of Nbs, for example by fusing the Nb to albumin, to prevent such rapid clearance and allow for maximal tumor uptake [45,46]. The gene discussed is ALB; the disease is neoplasm.